Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Orbimed Advisors, LLC and Directors liquidated all their common shares. Form 4 filed Nov. 25, 2022.
https://www.sec.gov/edgar/browse/?CIK=1595585&owner=exclude
>>> Move on to ELTP before a monster run.
Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed stock price @ 3.5 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
**************** Upward Growth *****************
-FY- ------------------ Revenue ---------------------------------Net Income
2019 ----------------7,568,508----------------------------------- (9,279,321)
2020 ---------------17,994,639----------------------------------- (2,240,351)
2021--------------- 25,380,749------------------------------------ 5,088,421
2022--------------- 32,262,117------------------------------------ 8,898,245
All in the company SEC filings
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
ELTP primed for the next Millionaire Maker run!!!
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
>>> First ever straight generic equivalent of oxycodone. No pharma company has entered the market yet to compete with Oxycodone as a generic.
>>> 2 abuse deterrents generic CNS stimulant
>>> ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed stock price @ 3.5 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
**************** Upward Growth *****************
-FY- ------------------ Revenue ---------------------------------Net Income
2019 ----------------7,568,508----------------------------------- (9,279,321)
2020 ---------------17,994,639----------------------------------- (2,240,351)
2021--------------- 25,380,749------------------------------------ 5,088,421
2022--------------- 32,262,117------------------------------------ 8,898,245
All in the company SEC filings
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
ELTP primed for the next Millionaire Maker run!!!
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
>>> First ever straight generic equivalent of oxycodone. No pharma company has entered the market yet to compete with Oxycodone as a generic.
>>> 2 abuse deterrents generic CNS stimulant
>>> ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed stock price @ 3.5 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
**************** Upward Growth *****************
-FY- ------------------ Revenue ---------------------------------Net Income
2019 ----------------7,568,508----------------------------------- (9,279,321)
2020 ---------------17,994,639----------------------------------- (2,240,351)
2021--------------- 25,380,749------------------------------------ 5,088,421
2022--------------- 32,262,117------------------------------------ 8,898,245
All in the company SEC filings
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
ELTP primed for the next Millionaire Maker run!!!
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
>>> First ever straight generic equivalent of oxycodone. No pharma company has entered the market yet to compete with Oxycodone as a generic.
>>> 2 abuse deterrents generic CNS stimulant
>>> ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed stock price @ 3.5 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
**************** Upward Growth *****************
-FY- ------------------ Revenue ---------------------------------Net Income
2019 ----------------7,568,508----------------------------------- (9,279,321)
2020 ---------------17,994,639----------------------------------- (2,240,351)
2021--------------- 25,380,749------------------------------------ 5,088,421
2022--------------- 32,262,117------------------------------------ 8,898,245
All in the company SEC filings
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
ELTP primed for the next Millionaire Maker run!!!
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
>>> First ever straight generic equivalent of oxycodone. No pharma company has entered the market yet to compete with Oxycodone as a generic.
>>> 2 abuse deterrents generic CNS stimulant
>>> ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed stock price @ 3.5 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
-FY- ------------------ Revenue ---------------------------------Net Income
2019 ----------------7,568,508----------------------------------- (9,279,321)
2020 ---------------17,994,639----------------------------------- (2,240,351)
2021--------------- 25,380,749------------------------------------ 5,088,421
2022--------------- 32,262,117------------------------------------ 8,898,245
All in the company SEC filings
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
ELTP primed for the next Millionaire Maker run!!!
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
>>> First ever straight generic equivalent of oxycodone. No pharma company has entered the market yet to compete with Oxycodone as a generic.
>>> 2 abuse deterrents generic CNS stimulant
>>> ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
Teva Pharmaceutical Names Richard Francis as CEO, President
Israeli drugmaker Teva Pharmaceutical Industries Ltd. said it named Richard Francis as president and chief executive, effective Jan. 1.
Teva, one of the largest makers of generic drugs, on Monday said Kare Schultz, who took the helm in 2017 amid falling profits, a large debt load and a declining share price, would retire at the end of the year.
Mr. Schultz earlier this month said he planned to step down when his contract expires in November 2023, but the company on Monday said he agreed to leave early to help facilitate an orderly transition.
Teva said Mr. Francis, 54 years old, currently serves as an operating partner for life-sciences investor Syncona Investment Management Ltd. and CEO of Syncona portfolio companies Purespring Therapeutics and Forcefield Therapeutics.
He previously spent five years as CEO of Novartis AG’s Sandoz generics and biosimilars division and 13 years as a senior executive at Biogen Inc.
https://www.wsj.com/articles/teva-pharmaceutical-names-richard-francis-as-president-ceo-11669034656?siteid=yhoof2
Kirkov's the man!!!
CEO NH -- "The rest of the products will be evaluated on case by case basis and figure out how we can bring them home or if it’s in our best interest to keep them with a partner. In addition to selling our products in the U.S., Elite has several opportunities for the sale of our products outside the United States. We continue to work on these details and look forward to successful sales in the future. Elite will provide updates on ongoing products and negotiations with overseas companies as we reach milestone or material events."
Nice!!! Thanks!
I totally agree!
A simple answer would be "I will file a complaint with the SEC" and will issue a press release upon submission. But he didn't which means no interest in doing so?
CEO --- "I read this question anyways. Is there any way to have the SEC investigate what is happening to Elite stock? The company is doing the right things. The CEO is managing risk properly, the revenues are going up. The company is cash flow positive and still the price of the stock goes down.
There is no logical explanation. You are correct. That’s all I can say. It’s very frustrating. We’re doing all the right things. Four or five years ago, the stock was $0.15 or even before that $0.30, when we were not making in any money. And now that we are actually a viable company where the profitable company, which you don’t see too many on the OTC that are or even on NASDAQ frankly.
We still the stock goes down. So there is no rhyme and reason with it. I’m hoping that all will change when we get more products, our own sales and marketing and maybe make a transition to a better exchange".
I hope he will surprise us to take action unto this matter.
I missed the cc. What was his answer on #2? TIA
Loving the SUSPENSE!!!:)
"and it would be "Uber Eats" bringing it to them under Kirkov's direction"
Darn you just gave me an idea! I'll be doing delivery with my soon to be company "Med Dash" ;))
Nice find. Thank you! This plus the ongoing settlements is a good signal towards Elite's quest in bringing back its ADF opioid drugs in development to commercialization. Welcome to ELTP board!
$10,750,100.00 Thanks!
Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed stock price @ 3 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
ELTP primed for the next Millionaire Maker run!!!
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
>>> First ever straight generic equivalent of oxycodone. No pharma company has entered the market yet to compete with Oxycodone as a generic.
>>> 2 abuse deterrents generic CNS stimulant
>>> ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
Yes! I'm seeing that single share too. Maybe a good sign going dollarland? :D
Wow the immediate outrageous reaction to your post. Must have really hit a nerve again. Even tried to bidwhacked just to make a point. LOL
Keep it up! Thank you!
New agreement in placed! --- With a multi-million$$$ TERMINATION FEE due Lannet for early termination regardless of any reason. :D
***Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed stock price @ 4 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
ELTP primed for the next Millionaire Maker run!!!
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
>>> First ever straight generic equivalent of oxycodone. No pharma company has entered the market yet to compete with Oxycodone as a generic.
>>> 2 abuse deterrents generic CNS stimulant
>>> ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed stock price @ 4 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
ELTP primed for the next Millionaire Maker run!!!
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
>>> First ever straight generic equivalent of oxycodone. No pharma company has entered the market yet to compete with Oxycodone as a generic.
>>> 2 abuse deterrents generic CNS stimulant
>>> ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
Hey folks! Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed stock price @ 4 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
ELTP primed for the next Millionaire Maker run!!!
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
>>> First ever straight generic equivalent of oxycodone. No pharma company has entered the market yet to compete with Oxycodone as a generic.
>>> 2 abuse deterrents generic CNS stimulant
>>> ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
Hey folks! Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed stock price @ 4 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
Will another Millionaire Maker run coming?
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
2 abuse deterrents
generic CNS stimulant
ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
ELTP!!! The next monster short squeeze in otc!!! Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed (NAKED SHORTED) stock price @ 4 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
Will another Millionaire Maker run coming?
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
2 abuse deterrents
generic CNS stimulant
ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
ELTP!!! >>> next monster short squeeze in otc!!! Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed (NAKED SHORTED) stock price @ 4 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
Will another Millionaire Maker run coming?
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
2 abuse deterrents
generic CNS stimulant
ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
ELTP!!! Folks next monster short squeeze in otc!!! Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed (NAKED SHORTED) stock price @ 4 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
Will another Millionaire Maker run coming?
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
2 abuse deterrents
generic CNS stimulant
ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
ELTP!!! The next monster short squeeze in otc!!! Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed (NAKED SHORTED) stock price @ 4 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
Will another Millionaire Maker run coming?
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
2 abuse deterrents
generic CNS stimulant
ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
ELTP!!! >>> next monster short squeeze in otc!!! Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed (NAKED SHORTED) stock price @ 4 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
Will another Millionaire Maker run coming?
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
2 abuse deterrents
generic CNS stimulant
ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
ELTP!!! >>>> next monster short squeeze in otc!!! Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed (NAKED SHORTED) stock price @ 4 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
Will another Millionaire Maker run coming?
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
2 abuse deterrents
generic CNS stimulant
ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
ELTP!!! >>> next monster short squeeze in otc!!! Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed (NAKED SHORTED) stock price @ 4 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
Will another Millionaire Maker run coming?
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
2 abuse deterrents
generic CNS stimulant
ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
ELTP!!! Folks next monster short squeeze in otc!!! Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed (NAKED SHORTED) stock price @ 4 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
Will another Millionaire Maker run coming?
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
2 abuse deterrents
generic CNS stimulant
ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
ELTP!!! Folks next monster short squeeze in otc!!! Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed (NAKED SHORTED) stock price @ 4 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
Will another Millionaire Maker run coming?
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
2 abuse deterrents
generic CNS stimulant
ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
GOVX was once an otc listed entity. Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed (NAKED SHORTED?) stock price @ 4 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
Will another Millionaire Maker run coming?
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
2 abuse deterrents
generic CNS stimulant
ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
All good and ready for ibox update. Thanks!
For the Years Ended March 31, 2022
Total revenue: $32,262,117 Change: 27.11%
Net income attributable to common shareholders: $8,898,245 Change: 74.87%
2022: https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
2021: https://www.sec.gov/ix?doc=/Archives/edgar/data/0001053369/000149315222018108/form10-k.htm
Thank you !!!
Still the Financial Ibox needs to be UPDATED. Any mods care?
This is main reason they can't afford losing Elite without drastically impacting their financial standpoint not to mention their current status. Why do you think Lannet discontinued their own recently approved Adderall ER?
Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed stock price @ 4 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
Will another Millionaire Maker run coming?
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
2 abuse deterrents
generic CNS stimulant
ADF adderall
Very rare to find an otc listed company with CASH FLOW POSITIVE status.